Michael Woeltje

Dr. Michael Woeltje

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Stem Cells
Verified
Journal Article
Closed access
PDF file
SNSabine Neuss
Sabine Neuss
EBEva Becher
Eva Becher
MWMichael Woeltje
Michael Woeltje
LTLothar Tietze
Lothar Tietze
WJWilli Jahnen-Dechent
Willi Jahnen-Dechent
STEM CELLS, a peer reviewed journal published monthly, provides a forum for prompt publication of original investigative papers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology. STEM CELLS welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. The journal covers all aspects of stem cells embryonic stem cells/induced pluripotent stem cells; tissue-specific stem cells; stem cell technology: epigenetics, genomics, proteomics, and metabonomics; cancer stem cells; translational and clinical research; and regenerative medicine.

15 November 2003 in Biochemical Journal
Verified
Journal Article
Closed access
BDBernd Denecke
Bernd Denecke
SGSteffen Gräber
Steffen Gräber
CSCora Schäfer
Cora Schäfer
AHAlexander Heiss
Alexander Heiss
MWMichael Woeltje
Michael Woeltje
WJWilli Jahnen-Dechent
Willi Jahnen-Dechent
Fetuins are serum proteins with diverse functions including the regulation of osteogenesis and inhibition of unwanted mineralization. Besides the α2-Heremans and Schmid glycoprotein/fetuin-A, the recently identified fetuin-B is a second member of the fetuin family [Olivier, Soury, Risler, Smih, Schneider, Lochner, Jouzeau, Fey and Salier (1999) Genomics 57, 352–364; Olivier, Soury, Ruminy, Husson, Parmentier, Daveau and Salier (2000) Biochem. J. 350, 589–597], which belongs to the cystatin superfamily. We compared the expressions of fetuin-B and fetuin-A at the RNA level and established that both genes are most highly expressed in liver tissue. Like fetuin-A, fetuin-B mRNA is also highly expressed in tongue and placenta tissues. We demonstrated for the first time that fetuin-B is also expressed at the protein level in sera and several organs of mouse, rat and human. We isolated contiguous genomic clones containing both fetuin-B and fetuin-A genes, indicating that these genes are closely linked at the genome level. The close proximity of both these genes may explain our observation that fetuin-B expression was decreased in fetuin-A-deficient mice. Unlike fetuin-A, the amount of fetuin-B protein in human serum varied with gender and was higher in females than in males. Functional analysis revealed that fetuin-B, similarly to fetuin-A, is an inhibitor of basic calcium phosphate precipitation, albeit less active when compared with fetuin-A. Therefore fetuin-B may have a function that is partly overlapping, if not identical, with the function of fetuin-A.

1 January 2008 in Biomaterials
Verified
Journal Article
Closed access
SNSabine Neuss
Sabine Neuss
CAChristian Apel
Christian Apel
PBPatricia Buttler
Patricia Buttler
BDBernd Denecke
Bernd Denecke
ADAnandhan Dhanasingh
Anandhan Dhanasingh
MZMartin Zenke
Martin Zenke

3 March 2009 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
KMKatrin Montzka
Katrin Montzka
NLNina Lassonczyk
Nina Lassonczyk
BTBeate Tschöke
Beate Tschöke
SNSabine Neuss
Sabine Neuss
TFTobias Fuehrmann
Tobias Fuehrmann
MWMichael Woeltje
Michael Woeltje
Background: In contrast to pluripotent embryonic stem cells, adult stem cells have been considered to be multipotent, being somewhat more restricted in their differentiation capacity and only giving rise to cell types related to their tissue of origin. Several studies, however, have reported that bone marrow-derived mesenchymal stromal cells (MSCs) are capable of transdifferentiating to neural cell types, effectively crossing normal lineage restriction boundaries. Such reports have been based on the detection of neural-related proteins by the differentiated MSCs. In order to assess the potential of human adult MSCs to undergo true differentiation to a neural lineage and to determine the degree of homogeneity between donor samples, we have used RT-PCR and immunocytochemistry to investigate the basal expression of a range of neural related mRNAs and proteins in populations of non-differentiated MSCs obtained from 4 donors. Results: The expression analysis revealed that several of the commonly used marker genes from other studies like nestin, Enolase2 and microtubule associated protein 1b (MAP1b) are already expressed by undifferentiated human MSCs. Furthermore, mRNA for some of the neural-related transcription factors, e.g. Engrailed-1 and Nurr1 were also strongly expressed. However, several other neural-related mRNAs (e.g. DRD2, enolase2, NFL and MBP) could be identified, but not in all donor samples. Similarly, synaptic vesicle-related mRNA, STX1A could only be detected in 2 of the 4 undifferentiated donor hMSC samples. More significantly, each donor sample revealed a unique expression pattern, demonstrating a significant variation of marker expression. Conclusion: The present study highlights the existence of an inter-donor variability of expression of neural-related markers in human MSC samples that has not previously been described. This donor-related heterogeneity might influence the reproducibility of transdifferentiation protocols as well as contributing to the ongoing controversy about differentiation capacities of MSCs. Therefore, further studies need to consider the differences between donor samples prior to any treatment as well as the possibility of harvesting donor cells that may be inappropriate for transplantation strategies.

1 February 2000 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
AZAlexander Zimprich
Alexander Zimprich
JKJürgen Kraus
Jürgen Kraus
MWMichael Woeltje
Michael Woeltje
PMPeter Mayer
Peter Mayer
ERElisabeth Rauch
Elisabeth Rauch
VHVolker Höllt
Volker Höllt
Prodynorphin, the precursor of the dynorphin opioid peptides, has been shown to play an important role in several aspects of human diseases and complex traits, e.g., drug abuse, epilepsy, and mood disorders. The objective of this study was to identify polymorphisms in the 5′ control region of the human prodynorphin gene and to relate these polymorphisms to prodynorphin gene expression. Within the core promoter region, a 68‐bp sequence was found to occur as a polymorphic element, either singular or as tandemly repeated element two, three, or four times. This 68‐bp repeat element contains an AP‐1 transcription factor binding site as demonstrated by electrophoretic mobility shift assay. Reporter gene assays were performed and provided evidence for allele dependent different promoter activity. Dynorphin was found to be involved in many pathophysiological processes so that the described prodynorphin alleles may correlate with the occurrence of several diseases, for example, drug addiction. However, prodynorphin allelic distributions were not significantly different in heroin addicts and control subjects.

16 March 2005 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
NTN. Tsuchida‐Straeten
N. Tsuchida‐Straeten
SES. Ensslen
S. Ensslen
CSC. Schäfer
C. Schäfer
MWMichael Woeltje
Michael Woeltje
BDB. Denecke
B. Denecke
WJWilli Jahnen-Dechent
Willi Jahnen-Dechent
Summary. Histidine-rich glycoprotein (HRG) is a serum protein belonging to the cystatin superfamily. HRG may play a regulatory role in hemostasis and innate immunity. However, this role is uncertain because of a lack of rigorous testing in an animal model. We generated mice lacking the translation start point of exon 1 of the Hrg gene, effectively resulting in a null mutation (Hrg–/–). The mice were viable and fertile but had no HRG in their blood. Antithrombin activity in the plasma of Hrg–/– mice was higher than in the plasma of heterozygous Hrg+/– or wild-type Hrg+/+ mice. The prothrombin time was shorter in Hrg–/– mice than in Hrg+/– and Hrg+/+ mice. Bleeding time after tail tip amputation in Hrg–/– mice was shorter than in Hrg+/+ mice. The spontaneous fibrinolytic activity in clotted blood of Hrg–/– mice was higher than in Hrg+/+ mice. These findings suggest that HRG plays a role as both an anticoagulant and an antifibrinolytic modifier, and may regulate platelet function in vivo.